Skip to main content

Table 1 Characteristics of patients with metastatic lung cancer and with management of chemotherapy in the public sector and access to FICHCOMP drugs: univariate and multivariate logistic regression analysis (multi-level analysis)

From: Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study

 

All patients (N = 11,486)

Patients with FICHCOMP drug use (N = 6959)

Univariate analysis

Multivariate analysis

n

(% col)a

n

(% row)b

OR [95% CI]

OR [95% CI]

Age at inclusion (years)

  ≤ 55 yrs

2923

(25.4%)

2058

(70.4%)

1.00

1.00

 56–65 yrs

4206

(36.6%)

2659

(63.2%)

0.72 [0.65–0.80]

0.76 [0.69–0.84]

  ≥ 66 yrs

4357

(37.9%)

2242

(51.5%)

0.44 [0.40–0.49]

0.49 [0.44–0.55]

Gender

 Men

8172

(71.1%)

4819

(59.0%)

0.79 [0.72–0.86]

0.86 [0.79–0.94]

 Women

3314

(28.9%)

2140

(64.6%)

1.00

1.00

Comorbidities

 Hypertension

2584

(22.5%)

1370

(53.0%)

0.68 [0.62–0.74]

0.88 [0.80–0.97]

 Diabetes

1151

(10.0%)

567

(49.3%)

0.61 [0.54–0.69]

0.79 [0.69–0.90]

 Renal insufficiency

224

(2.0%)

87

(38.8%)

0.41 [0.31–0.54]

0.55 [0.41–0.73]

 COPD

1506

(13.1%)

744

(49.4%)

0.60 [0.54–0.67]

0.71 [0.63–0.80]

 Pulmonary insufficiency

461

(4.0%)

225

(48.8%)

0.60 [0.50–0.73]

0.73 [0.60–0.88]

 Other chronic lung diseases

855

(7.4%)

444

(51.9%)

0.68 [0.59–0.78]

0.93 [0.79–1.08]

Type of hospital for first stay with chemotherapyc

 CH

5615

(48.9%)

3405

(60.6%)

1.00

 CHU

3284

(28.6%)

2019

(61.5%)

1.03 [0.95–1.13]

 CLCC

1193

(10.4%)

716

(60.0%)

0.93 [0.81–1.06]

 Others

1394

(12.1%)

819

(58.8%)

0.91 [0.80–1.03]

Population density of municipality (quartile; population nb hab/km2)c

 Very low density (≤ 86)

2891

(25.2%)

1693

(58.6%)

0.94 [0.83–1.06]

 Low density (]86–309])

2905

(25.3%)

1743

(60.0%)

1.02 [0.91–1.15]

 High density (]309–2073])

2872

(25.0%)

1772

(61.7%)

1.07 [0.95–1.21]

 Very high density (> 2073)

2818

(24.5%)

1751

(62.1%)

1.00

Social deprivation of municipality (quartile)

 Most deprived

3031

(26.4%)

1762

(58.1%)

0.82 [0.73–0.93]

0.82 [0.72–0.92]

 Deprived

3249

(28.3%)

1958

(60.3%)

0.90 [0.80–1.01]

0.87 [0.78–0.98]

 Privileged

2461

(21.4%)

1493

(60.7%)

0.93 [0.82–1.04]

0.90 [0.80–1.02]

 Most privileged

2745

(23.9%)

1746

(63.6%)

1.00

1.00

  1. COPD chronic obstructive respiratory disease, CH community hospital, CHU university hospital, CLCC cancer care clinic, OR odds ratio, 95%CI 95% confidence interval
  2. aPercentage calculated with total number of patients as the denominator (11486). bPercentage calculated as number of patients in class receiving FICHCOMP drugs. cNon-significant variable in the univariate analysis (threshold = 10%), therefore not included in the multivariate analysis